
XENE EPS Estimates
Xenon Pharmaceuticals Inc.
$37.78
+$0.03(+0.08%)
48
Overall
60
Value
45
Tech
39
Quality
Market Cap
$3.71B
Volume
959.33K
52W Range
$33.38 - $72.66
Target Price
$70.26
XENE EPS estimates: the consensus estimate for Xenon Pharmaceuticals Inc.'s current fiscal year is -$4.62 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
XENE EPS Estimates
- EPS estimate, current quarter
- $-1.21
- EPS estimate, next quarter
- $-1.22
- EPS estimate, current year
- $-4.62
- EPS estimate, next year
- $-4.72
- EPS growth, 3-year
- -28.39%
| Fiscal year | EPS |
|---|---|
| 2025 | $-4.36 |
| 2024 | $-3.01 |
| 2023 | $-2.73 |
| 2022 | $-2.06 |
| 2021 | $-1.77 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | XENE | $37.78 | +0.1% | 959.33K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Xenon Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW